Clinical trial
Randomized, Double Blinded, Placebo Controlled, Study to Evaluate Improvements in Glycemic Control, Lipid Levels, Quality of Life and Healthcare Costs After Daily Administration of Chromium Picolinate and Biotin in Patients With T2DM
NCT00289354 is registered in ClinicalTrials.gov with Nutrition 21, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double Blinded, Placebo Controlled, Study to Evaluate Improvements in Glycemic Control, Lipid Levels, Quality of Life and Healthcare Costs After Daily Administration of Chromium Picolinate and Biotin in Patients With T2DM
- Lead sponsor
- Nutrition 21, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2003
- Completion date
- November 30, 2005
- Enrollment
- 600
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.